Title,Abstract,Link,Disease_Verbs
Glioblastoma,Glioblastoma is the most aggressive and the most common primary malignant brain tumor in  adults. Risk factors for glioblastoma are  Standard treatment of glioblastoma comprises the,https://link.springer.com/chapter/10.1007/978-3-319-49864-5_18,['comprises']
The definition of primary and secondary glioblastoma,in secondary glioblastomas; EGF receptor (EGFR) overexpression prevailed in primary  glioblastomas but was rare in secondary glioblastomas. Only 1 of 49 glioblastomas showed,https://aacrjournals.org/clincancerres/article-abstract/19/4/764/78094,"['showed', 'prevailed']"
Management of glioblastoma: State of the art and future directions,Glioblastoma is the most common malignant primary brain  The recently revised classification  of glioblastoma based on  ultimately improve the outcome of patients with glioblastoma.,https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.3322/caac.21613,"['improve', 'based', 'revised']"
Glioblastoma in adults,"Glioblastoma (GBM) is the most malignant among astrocytic tumours and is associated with  a poor prognosis. Age, performance status, mini-mental status examination score,",https://www.sciencedirect.com/science/article/pii/S1040842808000450,['associated']
Current challenges and opportunities in treating glioblastoma,"Glioblastoma multiforme (GBM), the most common and aggressive primary brain tumor, has  a high mortality rate despite extensive efforts to develop new treatments. GBM exhibits both",https://pharmrev.aspetjournals.org/content/70/3/412.short,"['has', 'develop']"
Adult glioblastoma,"Glioblastoma (GBM) is a rare tumor and one of the most challenging malignancies to treat in  all of oncology. Although advances have been made in the treatment of GBM, encouraging",https://ascopubs.org/doi/abs/10.1200/JCO.2017.73.0119,['treat']
Treatment of glioblastoma,"Glioblastoma is the most common and most aggressive form  improvement in survival in  glioblastoma. This review discusses  of newly diagnosed and recurrent glioblastoma, as well as",https://ascopubs.org/doi/abs/10.1200/jop.2017.025536,"['discusses', 'diagnosed']"
Epidemiology and outcome of glioblastoma,"Glioblastoma (GBM) is the most aggressive malignant primary brain tumor. With an incidence  rate of 3.19 per 100,000 persons in the United States and a median age of 64 years, it is",https://exonpublications.com/index.php/exon/article/view/130,[]
Genetic pathways to primary and secondary glioblastoma,"During progression to glioblastoma, additional mutations accumulate, including loss of  in  both primary and secondary glioblastomas. Primary and secondary glioblastomas also differ",https://www.sciencedirect.com/science/article/pii/S0002944010613582,"['including', 'accumulate', 'differ']"
Glioblastoma multiforme–an overview,"Over 90% of diagnosed glioblastomas multiforme cases are primary gliomas,  glioblastomas  formation differ, morphologically they do not reveal any significant differences. Glioblastoma","https://www.termedia.pl/Glioblastoma-multiforme-an-overview,3,22235,0,1.html","['diagnosed', 'reveal', 'differ']"
"Glioblastoma: clinical presentation, diagnosis, and management","Glioblastoma is the most common primary brain cancer.  and rapidly progressive nature of  glioblastoma, close collaboration  Glioblastoma is the most common primary brain cancer in",https://www.bmj.com/content/374/bmj.n1560.short,[]
Immunotherapeutic advancements for glioblastoma,"Immunotherapy seeks to improve the body’s immune response to a tumor. Currently, the  principal mechanisms employed are: (1) to improve an aspect of the immune response (eg, T",https://www.frontiersin.org/articles/10.3389/fonc.2015.00012/full,[]
Glioblastoma: overview of disease and treatment,Background Glioblastoma (GBM) is the most common and aggressive malignant brain  tumor in adults. Current treatment options at diagnosis are multimodal and include surgical,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123811/,[]
"Glioblastoma: pathology, molecular mechanisms and markers",Recent advances in genomic technology have led to a better understanding of key molecular  alterations that underlie glioblastoma (GBM). The current WHO-based classification of,https://link.springer.com/article/10.1007/s00401-015-1432-1,['led']
How we treat glioblastoma,"Furthermore, classical glioblastoma does not exhibit  no longer be labelled glioblastomas  in future revisions of the  criteria of glioblastoma as tumours equivalent to glioblastoma, for",https://www.sciencedirect.com/science/article/pii/S2059702920326120,"['labelled', 'glioblastoma', 'exhibit']"
Genetic pathways to glioblastoma: a population-based study,"We conducted a population-based study on glioblastomas in the Canton of Zurich, Switzerland  (population, 1.16 million) to determine the frequency of major genetic alterations and",https://aacrjournals.org/cancerres/article-abstract/64/19/6892/511738,"['conducted', 'based', 'determine']"
Recent advances in the molecular understanding of glioblastoma,"These primary glioblastomas present in elderly patients with a brief clinical history and are   to secondary glioblastoma. A secondary glioblastoma occurs in ~5% of glioblastoma patients,",https://link.springer.com/article/10.1007/s11060-011-0793-0,['occurs']
Multidimensional communication in the microenvirons of glioblastoma,"properties of human glioblastoma (Box 1), especially regarding the analysis of glioblastoma   , evidence increasingly demonstrates that glioblastoma is genetically heterogeneous (Box 2",https://www.nature.com/articles/s41582-018-0025-8,"['regarding', 'demonstrates']"
Current concepts and management of glioblastoma,Glioblastoma is  of glioblastoma patients with a focus on the management of common  symptoms and complications. We aim to provide a guide for clinicians confronted with glioblastoma,https://onlinelibrary.wiley.com/doi/abs/10.1002/ana.22425,"['aim', 'provide', 'confronted']"
Glioblastoma and other malignant gliomas: a clinical review,"Importance Glioblastomas and malignant gliomas are the most common primary malignant  brain tumors, with an annual incidence of 5.26 per 100 000 population or 17 000 new",https://jamanetwork.com/journals/jama/article-abstract/1764056,[]
Current state of immunotherapy for glioblastoma,"-based therapeutic approaches for glioblastoma. Nevertheless, a range  for gliomas,  notably glioblastoma, the implications for  , and future directions for glioblastoma immuno-oncology.",https://www.nature.com/articles/s41571-018-0003-5,['-based']
Glioblastoma in england: 2007–2011,"Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumour in   The aim of this report is to examine the incidence of patients with glioblastoma in England,",https://www.sciencedirect.com/science/article/pii/S0959804915000039,['examine']
Radiotherapy for glioblastoma in the elderly,"astrocytomas, this analysis focuses solely on the 81 patients with glioblastoma. The  characteristics of the two groups of patients with glioblastoma were similar at baseline (Table 1). The",https://www.nejm.org/doi/abs/10.1056/NEJMoa065901,['focuses']
Glioblastoma [Internet],"Glioblastoma is the commonest and the most lethal brain tumor. In this book 71 experts from  around the globe come together to give a timely, unique and exhaustive compilation of",https://pubmed.ncbi.nlm.nih.gov/29251853/,[]
Epidemiology of glioblastoma multiforme–literature review,"Simple Summary Glioblastoma multiforme (GBM) is one of the most aggressive malignancies,  accounting for 14.5% of all central nervous system tumors and 48.6% of malignant central",https://www.mdpi.com/2072-6694/14/10/2412,['accounting']
Glioma and glioblastoma‑how much do we (not) know?,"glioblastomas are more common among younger patients. They arise as low-grade tumors  and, over a few years, they progress to glioblastomas.  As regards secondary glioblastomas,",https://www.spandidos-publications.com/mco/1/6/935,"['arise', 'regards', 'progress']"
Treatment of glioblastoma in adults,glioblastoma strongly associated with glioblastoma progressive from a lower grade glioma.  The existence of de novo IDH-mutated glioblastoma  genetic alteration in glioblastoma and is,https://journals.sagepub.com/doi/abs/10.1177/1756286418790452,"['mutated', 'associated']"
Advances in the management of glioblastoma,"Glioblastoma (GB) is the most common and most malignant primary brain tumour in adults.  Despite much effort, gold standard therapy has not changed since the introduction of",https://jnnp.bmj.com/content/92/10/1103.abstract,[]
Emerging therapies for glioblastoma,"Importance Glioblastoma is the most common primary malignant brain tumor, but despite  multimodal treatment with surgery, radiotherapy, and temozolomide chemotherapy, the",https://jamanetwork.com/journals/jamaneurology/article-abstract/1905924,[]
Recent advances in therapy for glioblastoma,"Glioblastoma is the most common primary malignant brain tumor in adults and is a challenging  disease to treat. The current standard of care includes maximal safe surgical resection,",https://jamanetwork.com/journals/jamaneurology/article-abstract/799492,['treat']
Epidemiologic and molecular prognostic review of glioblastoma,Glioblastoma multiforme (GBM) is the most common and aggressive primary central nervous  system malignancy with a median survival of 15 months. The average incidence rate of,https://aacrjournals.org/cebp/article-abstract/23/10/1985/14199,[]
Assumptions in the radiotherapy of glioblastoma,"of glioblastoma: (1) No neuroradiologic technique provides an accurate delineation of tumor  bulk and location, (2) glioblastoma is  CT scans, performed on glioblastoma patients within 2",https://www.neurology.org/doi/abs/10.1212/WNL.30.9.907,"['performed', 'provides']"
Glioblastoma stem cells,Glioblastomas are highly malignant primary brain tumors with one of the worst survival rates  among all human cancers. With a more profound understanding of the cellular and,https://link.springer.com/article/10.1007/s00441-010-1123-0,[]
Glioblastoma multiforme: the terminator,"Glioblastoma multiforme is the most aggressive of the gliomas, a collection of tumors arising  from glia or their precursors within the central nervous system. Clinically, gliomas are",https://www.pnas.org/doi/abs/10.1073/pnas.97.12.6242,['arising']
Glioblastoma multiforme: Pathogenesis and treatment,"Each year, about 5–6 cases out of 100,000 people are diagnosed with primary malignant  brain tumors, of which about 80% are malignant gliomas (MGs). Glioblastoma multiforme (GBM",https://www.sciencedirect.com/science/article/pii/S0163725815000960,[]
Glioblastoma: defining tumor niches,"Glioblastomas (glioblastoma multiforme, GBM) are one of the most recalcitrant brain tumors  because of their aggressive invasive growth and resistance to therapy. They are highly",https://www.cell.com/trends/cancer/fulltext/S2405-8033(15)00056-4,[]
Molecular targeted therapy of glioblastoma,"Glioblastomas are intrinsic brain tumors thought to originate from neuroglial stem or progenitor  cells. More than 90% of glioblastomas are  , there are no known glioblastoma risk factors.",https://www.sciencedirect.com/science/article/pii/S0305737219301124,"['thought', 'are', 'originate']"
Immunosuppressive mechanisms in glioblastoma,"therapy, the treatment of glioblastoma remains a seriously vexing  molecular characterization  of glioblastoma and glioblastoma cancer stem  in glioblastoma and therapeutic approaches.",https://academic.oup.com/neuro-oncology/article-abstract/17/suppl_7/vii9/2472611,"['vexing', 'remains']"
Long-term survival with glioblastoma multiforme,analysis of 55 primary glioblastoma long-term survivors  141 consecutive unselected  glioblastoma patients registered  underline the association of glioblastoma long-term survival,https://academic.oup.com/brain/article-abstract/130/10/2596/376628,"['underline', 'registered']"
A review of glioblastoma immunotherapy,This review aims to provide an overview of the current state of glioblastoma immunotherapy.   glioblastoma have largely been disappointing for both primary and recurrent glioblastoma.,https://link.springer.com/article/10.1007/s11060-020-03448-1,"['aims', 'provide']"
An integrated genomic analysis of human glioblastoma multiforme,"Glioblastoma multiforme (GBM) is the most common and lethal type of brain cancer. To identify  the genetic alterations in GBMs, we sequenced 20,661 protein coding genes, determined",https://www.science.org/doi/abs/10.1126/science.1164382,[]
Glioblastoma,"and comprehensive look at glioblastoma, and emerge  glioblastoma. With the enthusiastic  participation of luminaries in neuro-oncology, we redefine the numerous facets of glioblastoma",https://books.google.com/books?hl=en&lr=&id=ZY83DQAAQBAJ&oi=fnd&pg=PP1&dq=glioblastoma&ots=JAnmKjNcuY&sig=MJy0rbJtjtdaaJrdbRcFkso-Xx0,"['emerge', 'redefine']"
Therapy for glioblastoma: is it working?,"types – almost half of which are highly aggressive glioblastomas (GBM) 2, 3. GBM is   identified 24 889 PubMed citations for the keywords ‘glioblastoma and/or glioma’ over the 5",https://www.sciencedirect.com/science/article/pii/S1359644618301880,['identified']
Survival in glioblastoma: a review on the impact of treatment modalities,Glioblastoma (GBM) is the most common and lethal tumor of the central nervous system. The  natural history of treated GBM remains very poor with 5-year survival rates of 5 %. Survival,https://link.springer.com/article/10.1007/s12094-016-1497-x,[]
"Frontiers in the treatment of glioblastoma: Past, present and emerging","Glioblastoma (GBM) is one of the most aggressive cancers of the brain. Despite extensive  research over the last several decades, the survival rates for GBM have not improved and",https://www.sciencedirect.com/science/article/pii/S0169409X21000223,[]
Present and potential future issues in glioblastoma treatment,Another method of improving glioblastoma patient treatment involves the prolonged use of   proliferating glioblastoma cells but not migrating glioblastoma cells. Migrating glioblastoma,https://www.tandfonline.com/doi/abs/10.1586/14737140.6.5.719,"['involves', 'migrating', 'improving', 'prolonged', 'proliferating']"
Survival in glioblastoma: historical perspective,": The accumulated retrospective experience with glioblastoma multiforme was reviewed. Data  were extracted from 17 reports in the literature, comprising 2532 patients. Survival curves",https://journals.lww.com/neurosurgery/abstract/1980/11000/Survival_in_Glioblastoma__Historical_Perspective.1.aspx,"['reviewed', 'accumulated']"
Glioblastoma: molecular analysis and clinical implications,evidence clearly indicates that glioblastoma is a molecularly  enticing possibility that  glioblastoma subclasses themselves  of molecular subclass in glioblastoma through both,https://www.annualreviews.org/content/journals/10.1146/annurev-med-100711-143028,"['indicates', 'subclasses']"
A comprehensive profile of recurrent glioblastoma,"glioblastoma is just slowly emerging. Here, we review current knowledge on recurrent  glioblastoma  , molecular traits and growth pattern of glioblastoma, and to which extent this",https://www.nature.com/articles/onc201685,"['review', 'emerging']"
Current standards of care in glioblastoma therapy,"Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. Regardless  of ideal multidisciplinary treatment, including maximal surgical resection, followed by",https://exonpublications.com/index.php/exon/article/view/133,[]
Glioblastoma multiforme: a review of where we have been and where we are going,"Malignant gliomas such as glioblastoma multiforme (GBM) present some of the greatest  challenges in the management of cancer patients worldwide, despite notable recent",https://www.tandfonline.com/doi/abs/10.1517/13543780903052764,['present']
Glioblastoma subtypes revisited,"Glioblastoma (GBM) was previously classified into four subtypes (classical, neural, proneural,  and mesenchymal) based on transcriptional features; however, the original classification,",https://www.nature.com/articles/nrclinonc.2017.122,"['classified', 'based']"
A prospective study on glioblastoma in the elderly,"BACKGROUND Elderly patients (age > 65 years) with glioblastoma multiforme frequently are  excluded from clinical studies, and prospective trials for patients with this age group do not",https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.11097,"['excluded', 'do']"
Glioblastoma: morphologic and molecular genetic diversity,"Context.—Glioblastoma (GBM), the most common primary intracranial malignancy, is a  morphologically diverse neoplasm with dismal prognosis despite multimodality therapy. Only 3",https://meridian.allenpress.com/aplm/article-abstract/131/3/397/460164,[]
"Glioblastoma: therapeutic challenges, what lies ahead","Glioblastoma (GBM) is one of the most aggressive human cancers. Despite current advances  in multimodality therapies, such as surgery, radiotherapy and chemotherapy, the outcome",https://www.sciencedirect.com/science/article/pii/S0304419X12000443,[]
The evidence of glioblastoma heterogeneity,"Cancers are composed of heterogeneous combinations of cells that exhibit distinct phenotypic  characteristics and proliferative potentials. Because most cancers have a clonal origin,",https://www.nature.com/articles/srep07979/briefing/signup,[]
"An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment","the last 3 years’ findings in glioblastoma characterization, its  personalized characterization  of glioblastoma in patients,  several noncoding RNAs in glioblastoma progression. Astrocyte-",https://onlinelibrary.wiley.com/doi/abs/10.1002/cac2.12361,['personalized']
Glioblastoma,"There is consensus that glioblastoma may arise de novo, designated primary glioblastoma,   grade gliomas with the designation of secondary glioblastoma. Each pathway has distinct",https://www.sciencedirect.com/science/article/pii/B9780444535023000045,"['arise', 'designated', 'is']"
Glioblastoma multiforme: a clinical survey,"CORDING tO Cushing s there were only two operations for brain tumour at the Johns Hopkins  Hospital prior to 1901. At a time when surgical specimens were a rarity, and most of the",https://thejns.org/view/journals/j-neurosurg/17/4/article-p736.xml,[]
Emerging insights into the molecular and cellular basis of glioblastoma,These comprehensive data sets reveal “glioblastoma” as a heterogeneous  glioblastoma  and focus on emerging insights into critical molecular pathways central to glioblastoma,https://genesdev.cshlp.org/content/26/8/756.short,"['glioblastoma', 'emerging', 'focus', 'reveal']"
Ten-year survival in glioblastoma. A systematic review,Glioblastoma (GBM) is among the most deadly neoplasms associated with one of the worst  5-year overall survival (OS) rates among all human cancers. The aim of this systematic,https://www.sciencedirect.com/science/article/pii/S0967586817317216,['associated']
New approaches to glioblastoma,"Faced with unique immunobiology and marked heterogeneity, treatment strategies for  glioblastoma require therapeutic approaches that diverge from conventional oncological strategies",https://www.annualreviews.org/content/journals/10.1146/annurev-med-042420-102102,"['require', 'diverge', 'Faced']"
The somatic genomic landscape of glioblastoma,We describe the landscape of somatic genomic alterations based on multidimensional and  comprehensive characterization of more than 500 glioblastoma tumors (GBMs). We identify,https://www.cell.com/cell/fulltext/S0092-8674(13)01208-7,"['describe', 'based']"
Emerging therapies for glioblastoma: current state and future directions,"of glioblastoma are rapidly translated into innovative clinical trials, utilizing improved  genetic and epigenetic profiling of glioblastoma as  perspectives in glioblastoma immuno-oncology.",https://link.springer.com/article/10.1186/s13046-022-02349-7,"['translated', 'improved', 'utilizing']"
Glioblastoma multiforme: morphology and biology,"The astrocytic nature of most glioblastomas has been  low growth fraction of glioblastoma.  The frequent occurrence of  Vascular proliferation, a characteristic feature of glioblastoma,",https://link.springer.com/article/10.1007/BF01406628,[]
Molecular and cellular heterogeneity: the hallmark of glioblastoma,The identification of a subpopulation of brain tumor cells termed “glioblastoma cancer stem   glioblastoma and emphasize that we should begin to consider each individual glioblastoma,https://thejns.org/focus/view/journals/neurosurg-focus/37/6/article-pE11.xml,"['emphasize', 'begin', 'consider', 'termed']"
Glioblastoma and stem cells-Minireview,evidence that human glioblastoma is a heterogenous tumor  Cancer stem cells derived from  glioblastoma are capable  and recurrence after conventional glioblastoma therapy. Cancer,https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=e509aca5fe96f4df2a973515a91ec2e022def8d6,['derived']
Emerging biomarkers in glioblastoma,"Glioblastoma, the most common primary brain tumor, has few available therapies providing  significant improvement in survival. Molecular signatures associated with tumor",https://www.mdpi.com/2072-6694/5/3/1103,"['has', 'providing']"
Electrotherapies for glioblastoma,"Non‐thermal, intermediate frequency (100–500 kHz) electrotherapies present a unique  therapeutic strategy to treat malignant neoplasms. Here, pulsed electric fields (PEFs) which",https://onlinelibrary.wiley.com/doi/abs/10.1002/advs.202100978,[]
Advances in local therapy for glioblastoma—taking the fight to the tumour,"Despite advances in neurosurgery, chemotherapy and radiotherapy, glioblastoma remains  one of  In this Review, we discuss the latest developments in local therapy for glioblastoma,",https://www.nature.com/articles/s41582-022-00621-0,"['discuss', 'remains']"
Glioblastoma,"Glioblastoma (GBM) is a disease that strikes without warning, often manifested by new  onset seizure or a few days of progressive focal weakness, numbness, or headache, yet",https://www.sciencedirect.com/science/article/pii/B9780443191763000479,"['manifested', 'strikes']"
A critical overview of targeted therapies for glioblastoma,"of glioblastoma patients. Refinements in surgery are mentioned because most of the patients  with glioblastoma  However, cure of glioblastoma has remained elusive because it requires",https://www.frontiersin.org/articles/10.3389/fonc.2018.00419/full,"['remained', 'mentioned', 'requires']"
Harnessing the immune system in glioblastoma,"of immune escape employed by glioblastoma, and the immunological effects of conventional  glioblastoma treatments. Novel therapies for glioblastoma that harness the immune system",https://www.nature.com/articles/s41416-018-0258-8,"['harness', 'employed']"
Molecular mechanisms of treatment resistance in glioblastoma,"molecular mechanisms underlying glioblastoma’s treatment  a glioblastoma tumor’s centrally  necrotic, hypoxic core, and less-hypoxic periphery [16]. Indeed, hypoxic glioblastoma cells",https://www.mdpi.com/1422-0067/22/1/351,['underlying']
Hallmarks of glioblastoma: a systematic review,"Despite decades of intense research, the complex biology of glioblastoma (GBM) is not  completely understood. Progression-free survival and overall survival have remained",https://www.sciencedirect.com/science/article/pii/S2059702920325035,['understood']
Standards of care for treatment of recurrent glioblastoma—are we there yet?,Newly diagnosed glioblastoma is now commonly treated  The treatment of recurrent  glioblastoma continues to be a  treatment of recurrent or progressive glioblastoma with,https://academic.oup.com/neuro-oncology/article-abstract/15/1/4/1373604,"['diagnosed', 'continues', 'treated']"
"Radiotherapy in Glioblastoma: the Past, the Present and the Future","glioblastoma over the past 60 years. Together with surgery, radiotherapy has always been  the cornerstone of treatment of glioblastoma of patients with glioblastoma. Radiation oncology",https://www.sciencedirect.com/science/article/pii/S0936655516303168,[]
Cancer stem cells in glioblastoma,"Tissues with defined cellular hierarchies in development and homeostasis give rise to tumors  with cellular hierarchies, suggesting that tumors recapitulate specific tissues and mimic",https://genesdev.cshlp.org/content/29/12/1203.short,[]
Angiogenesis in glioblastoma,One pathologic feature of glioblastoma multiforme that distinguishes it from lower-grade glial  tumors is microvascular proliferation. Glioblastoma multiforme is highly vascular. Several,https://www.nejm.org/doi/full/10.1056/nejmcibr1309402,['distinguishes']
New directions in the therapy of glioblastoma,"Glioblastoma is the most common histologic type of all  on novel targeted therapies in  glioblastoma. Based on recent studies,  This paper focused on drugs that target major",https://www.mdpi.com/2072-6694/14/21/5377,['targeted']
Current management of glioblastoma multiforme,"it is referred to as a secondary glioblastoma. The low-grade astrocytomas often  glioblastoma  is associated with amplification of EGFR or MDM2 genes. In contrast, primary glioblastomas",https://www.sciencedirect.com/science/article/pii/S0093775404003276,"['referred', 'associated']"
Immunotherapy advances for glioblastoma,"Survival for patients with glioblastoma, the most common high-grade primary CNS tumor,  remains poor despite multiple therapeutic interventions including intensifying cytotoxic therapy,",https://academic.oup.com/neuro-oncology/article-abstract/16/11/1441/2509074,"['including', 'intensifying', 'remains']"
Glioblastoma treatments: an account of recent industrial developments,"The different drugs and medical devices, which are commercialized or under industrial  development for glioblastoma treatment, are reviewed. Their different modes of action are",https://www.frontiersin.org/articles/10.3389/fphar.2018.00879/full,"['commercialized', 'reviewed']"
Insights in the immunobiology of glioblastoma,to distinct functional phenotypes contributes to glioblastoma (GB)  Glioblastoma (GB) refers  to grade IV diffuse astrocytoma and  A third group encompasses glioblastoma tumors that IDH,https://link.springer.com/article/10.1007/s00109-019-01835-4,"['distinct', 'grade', 'contributes', 'encompasses', 'diffuse', 'refers']"
Chemotherapy resistance of glioblastoma stem cells,"of glioblastoma cells to cytotoxic agents in vitro. 3, 4 Moreover, the short interval for tumor  recurrence in glioblastoma  and in vivo model for studying glioblastoma response to treatments.",https://www.nature.com/articles/4401872,['studying']
The treatment of glioblastoma multiforme of the brain,"However, as we are constantly confronted with the problem of how best to deal with the  unfortunate patients suffering from these tumors, we must constantly strive to improve our",https://thejns.org/view/journals/j-neurosurg/27/5/article-p388.xml,[]
Current trends in mouse models of glioblastoma,"analyses reported for human glioblastoma, this review  of glioblastoma. Further, we focus  on the clinical value of these models by examining their contributions to studies of glioblastoma",https://link.springer.com/article/10.1007/s11060-017-2626-2,"['examining', 'reported', 'focus']"
Glioblastoma and miRNAs,"Glioblastoma (GB) is one of the most common types of lethal brain tumors. Although several  treatment options are available including surgery, along with adjuvant chemo and",https://www.mdpi.com/2072-6694/13/7/1581?utm_campaign=releaseissue_cancersutm_medium=emailutm_source=releaseissueutm_term=doilink13,[]
"Glioblastoma multiforme, diagnosis and treatment; recent literature review","Background: Glioblastoma multiforme (GBM) is the most common malignant primary brain  tumor, with an incidence of 3.19 cases per 100,000 person years and remarkably poor",https://www.ingentaconnect.com/content/ben/cmc/2017/00000024/00000027/art00010,[]
A review of newly diagnosed glioblastoma,"marker of secondary glioblastoma because of its  to glioblastoma. Given the increasing  importance of molecular subtyping in glioblastoma (22), the WHO has classified glioblastoma into",https://www.frontiersin.org/articles/10.3389/fonc.2020.574012/full,"['Given', 'classified', 'increasing']"
Drug resistance in glioblastoma: a mini review,of glioblastoma patients over the past 10 years. The 5-year survival rate of glioblastoma   is an important goal for the treatment of glioblastomas. This review will concentrate on the,https://link.springer.com/article/10.1007/s11064-011-0701-1,[]
Glioblastoma and other primary brain malignancies in adults: a review,c IDH-wild-type glioblastomas lack mutations in IDH1 and IDH2. Absence of  IDH-wild-type  glioblastoma in patients aged 55 years and older with histologically classic glioblastoma.,https://jamanetwork.com/journals/jama/article-abstract/2801673,['aged']
Radiation therapy of glioblastoma,"for glioblastoma, and it remains the primary treatment modality in unresectable glioblastoma  This chapter focuses on the evolution of RT in the treatment of glioblastoma, with the goal of",https://link.springer.com/chapter/10.1007/978-3-319-12048-5_4,"['focuses', 'remains']"
Immunocytokines are a promising immunotherapeutic approach against glioblastoma,"Glioblastoma is a poorly immunogenic cancer, and the successes with recent immunotherapies  in extracranial malignancies have, so far, not been translated to this devastating disease",https://www.science.org/doi/abs/10.1126/scitranslmed.abb2311,['translated']
Current trends in the surgical management and treatment of adult glioblastoma,"of glioblastoma. This paper highlights the common pathophysiology attributes of glioblastoma,   Glioblastoma is not a disease that can be cured with surgery alone, however safely",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481356/,"['highlights', 'cured']"
MicroRNA in glioblastoma: an overview,"Glioblastoma is the most aggressive brain tumor and, even with the current multimodal  therapy, is an invariably lethal cancer with a life expectancy that depends on the tumor subtype",https://onlinelibrary.wiley.com/doi/abs/10.1155/2017/7639084,['depends']
Glioblastoma: microenvironment and niche concept,"The niche concept was originally developed to describe the location of normal neural stem  cells (NSCs) in the subependymal layer of the sub-ventricular zone. In this paper, its",https://www.mdpi.com/2072-6694/11/1/5,[]
Immunotherapy for glioblastoma: current progress and challenges,"in glioblastoma. Herein, we review the primary ongoing immunotherapy candidates for  glioblastoma with  may pave the way for more effective immunotherapeutics against glioblastoma.",https://www.frontiersin.org/articles/10.3389/fimmu.2021.676301/full,"['review', 'pave']"
Reoperation for glioblastoma,✓ The results of a second operation for tumor removal in 24 adult patients with supratentorial  glioblastoma multiforme or anaplastic astrocytoma were analyzed. The median survival,https://thejns.org/view/journals/j-neurosurg/55/6/article-p917.xml,['analyzed']
Challenges in glioblastoma research: focus on the tumor microenvironment,"Glioblastoma (GBM) is the most deadly type of malignant brain tumor, despite extensive  molecular analyses of GBM cells. In recent years, the tumor microenvironment (TME) has been",https://www.cell.com/trends/cancer/fulltext/S2405-8033(22)00220-5?dgcid=raven_jbs_aip_email,[]
Survival in patients with glioblastoma receiving valganciclovir,"In the Valcyte Treatment of Glioblastoma Patients in Sweden (VIGAS) study, 5 a double-blind  clinical trial of valganciclovir involving 42 patients with glioblastoma, we found that tumor growth",https://www.nejm.org/doi/full/10.1056/nejmc1302145,"['found', 'involving']"
Glioblastoma treatment: state-of-the-art and future perspectives,"Nevertheless, patients with glioblastoma still have a poor prognosis. Therefore,  in glioblastoma  patients. (2) Methods: Our objective is to recap the actual state-of-the-art in glioblastoma",https://www.mdpi.com/1422-0067/23/13/7207,"['have', 'recap']"
Glioblastoma: from molecular pathology to targeted treatment,"Glioblastoma (GBM) is one of the most lethal human cancers. Genomic analyses are defining  the molecular architecture of GBM, uncovering relevant subsets of patients whose disease",https://www.annualreviews.org/content/journals/10.1146/annurev-pathol-011110-130324,[]
Advances and challenges in the treatment of glioblastoma: a clinician's perspective,"Glioblastoma (GBM) is the most deadly form of human cancer. Most patients diagnosed with  this WHO grade IV malignant glioma survive about 12 months. Despite international efforts,",https://www.discoverymedicine.com/Maciej-M-Mrugala/2013/04/25/advances-and-challenges-in-the-treatment-of-glioblastoma-a-clinicians-perspective/,[]
Heterogeneity maintenance in glioblastoma: a social network,"Glioblastoma multiforme (GBM), the most common intracranial tumor in adults, is characterized  by extensive heterogeneity at the cellular and molecular levels. This insidious feature",https://aacrjournals.org/cancerres/article-abstract/71/12/4055/567601,['characterized']
Glioblastoma treatment modalities besides surgery,"Glioblastoma multiforme (GBM) is commonly known as the most aggressive primary CNS  tumor in adults. The mean survival of it is 14 to 15 months, following the standard therapy from",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775524/,['known']
Comparison of glioblastoma (GBM) molecular classification methods,Glioblastoma (GBM) is the most aggressive and common form of brain cancer in adults.  GBM is characterized by poor survival and remarkably high tumors heterogeneity (both,https://www.sciencedirect.com/science/article/pii/S1044579X18300415,[]
An anatomic transcriptional atlas of human glioblastoma,"Ivy Glioblastoma Atlas, an anatomically based transcriptional atlas of human glioblastoma   .alleninstitute.org/), a comprehensive molecular pathology map of glioblastoma in which we",https://www.science.org/doi/abs/10.1126/science.aaf2666,['based']
Survival outcomes and prognostic factors in glioblastoma,Background: IDH-wildtype glioblastoma is the most common  study to characterise the  glioblastoma population at our  for patients diagnosed with glioblastoma at our centre between,https://www.mdpi.com/2072-6694/14/13/3161,"['diagnosed', 'characterise']"
Current medical treatment of glioblastoma,Glioblastoma is the most common adult malignant primary brain tumor.  with glioblastoma  remains dismal at 15–18 months. Current standard of care for newly diagnosed glioblastoma is,https://link.springer.com/chapter/10.1007/978-3-319-12048-5_7,"['diagnosed', 'remains']"
Glioblastoma targeted therapy: updated approaches from recent biological insights,discuss challenges and opportunities for the development of these agents in glioblastoma.   Genomic landscape of glioblastoma Glioblastomas constitute a highly heterogeneous group,https://www.sciencedirect.com/science/article/pii/S0923753419322483,"['discuss', 'constitute']"
"Management of glioblastoma, present and future",Glioblastomas are the most common malignant brain tumor and despite extensive research  have a dismal prognosis. This review focuses on the current treatment paradigms of,https://www.sciencedirect.com/science/article/pii/S1878875019319503,['have']
Lomustine and bevacizumab in progressive glioblastoma,Background Bevacizumab is approved for the treatment of patients with progressive glioblastoma  on the basis of uncontrolled data. Data from a phase 2 trial suggested that the addition,https://www.nejm.org/doi/full/10.1056/NEJMoa1707358,['approved']
Life beyond a diagnosis of glioblastoma: a systematic review of the literature,"glioblastoma is 12–14 months with less than 10% of patients surviving at least 2 years from  diagnosis. Patients diagnosed with glioblastoma  -term survivors of glioblastoma, a small but",https://link.springer.com/article/10.1007/s11764-017-0602-7,"['diagnosed', 'surviving']"
Overcoming therapeutic resistance in glioblastoma: the way forward,Glioblastoma is the most common and lethal primary  of tumor heterogeneity in glioblastoma  and provide new insights into  both need to be targeted to prevent glioblastoma recurrence.,https://www.jci.org/articles/view/89587,"['need', 'targeted', 'provide', 'prevent']"
Glioblastoma multiforme: a review of therapeutic targets,"Glioblastoma is the commonest primary brain tumor, as well as the deadliest. Malignant  gliomas such as glioblastoma multiforme (GBM) present some of the greatest challenges in the",https://www.tandfonline.com/doi/abs/10.1517/14728220902942348,['present']
Advanced magnetic resonance imaging in glioblastoma: a review,"Glioblastoma,  glioblastoma is magnetic resonance imaging (MRI), which is a widely utilized  examination in the diagnosis and post-treatment management of patients with glioblastoma.",https://cco.amegroups.org/article/view/15820,['utilized']
Management of glioblastoma,Glioblastoma multiforme (GBM) are among the most devastating neoplasms claiming the  lives of patients within a median of 1 year after diagnosis. Treatment of GBM requires a,https://www.tandfonline.com/doi/abs/10.1517/14656566.8.18.3133,['claiming']
Glioblastoma multiforme in children,children with glioblastoma multiforme was significantly increased with steroid therapy.  Glioblastoma multiforme behaves similarly in children and adults. Intracranial glioblastomas have,https://thejns.org/view/journals/j-neurosurg/44/4/article-p442.xml,"['behaves', 'have', 'increased']"
Glioblastoma—treatment and obstacles,"Background: Glioblastoma is the most common and  Results: The standard of care for  glioblastoma is the maximum  In recurrent glioblastoma, it is necessary to balance the risks and",https://journals.viamedica.pl/rpor/article/view/90766,['balance']
Clonal evolution of glioblastoma under therapy,"Glioblastoma (GBM) is the most common and aggressive primary brain tumor. To better  understand how GBM evolves, we analyzed longitudinal genomic and transcriptomic data from",https://www.nature.com/articles/ng.3590,[]
Current surgical management of glioblastoma,"Surgical resection is a critical aspect of the management of a patient with a glioblastoma (GBM).  An intimate knowledge of the anatomy of a GBM, as well as familiarity with particular",https://journals.lww.com/journalppo/fulltext/2003/03000/Current_Surgical_Management_of_Glioblastoma.7.aspx,[]
Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art,"Glioblastoma multiforme, a grade IV glioma, is the most frequently occurring and invasive  primary tumor of the central nervous system, which causes about 4% of cancer-associated-",https://www.sciencedirect.com/science/article/pii/S0168365916300797,"['occurring', 'causes']"
Glioblastoma clinical trials: current landscape and opportunities for improvement,of all glioblastoma trials and allowance for prior bevacizumab use in about two thirds of  recurrent glioblastoma trials. Our analysis also found that 47% of current glioblastoma clinical,https://aacrjournals.org/clincancerres/article-abstract/28/4/594/678102,"['use', 'found']"
Imaging glioblastoma multiforme,"Glioblastoma multiforme are infiltrative lesions that have a high degree of heterogeneity,  both within and between different patients. Imaging is critical for all phases in the evaluation",https://journals.lww.com/journalppo/fulltext/2003/03000/imaging_glioblastoma_multiforme.9.aspx,['have']
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance,"Glioblastoma multiforme (GBM) is a WHO grade IV glioma and the most common malignant,  primary brain tumor with a 5-year survival of 7.2%. Its highly infiltrative nature, genetic",https://www.sciencedirect.com/science/article/pii/S1043661821003649,[]
The p53 pathway in glioblastoma,Glioblastoma patients typically present with de novo grade IV lesions delineating primary  glioblastoma ( progress into grade IV lesions delineating secondary glioblastoma [12]. One of,https://www.mdpi.com/2072-6694/10/9/297,"['present', 'delineating', 'lesions']"
Current data and strategy in glioblastoma multiforme,"Glioblastoma multiforme (GBM) or astrocytoma grade Ⅳ on WHO classification is the most  aggressive and the most frequent of all primary brain tumors. Glioblastoma is multiforme,",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019011/,[]
Extensive modulation of a set of microRNAs in primary glioblastoma,"glioblastoma multiforme, the most frequent and malignant of primary brain tumors. The analysis  of both glioblastoma tissues and glioblastoma  up-regulated in glioblastoma and from a",https://www.sciencedirect.com/science/article/pii/S0006291X05014816,['regulated']
A restricted cell population propagates glioblastoma growth after chemotherapy,"Glioblastoma multiforme is the most common primary malignant brain tumour, with a median  survival of about one year 1 . This poor prognosis is due to therapeutic resistance and",https://www.nature.com/articles/nature11287,[]
Novel delivery strategies for glioblastoma,"Brain tumors—particularly glioblastoma multiforme—pose an important public health problem  in the United States. Despite surgical and medical advances, the prognosis for patients",https://journals.lww.com/journalppo/FullText/2012/01000/Novel_Delivery_Strategies_for_Glioblastoma.14.aspx,['pose']
The EGFRvIII variant in glioblastoma multiforme,"Glioblastoma multiforme (GBM) is the most common brain tumour and has the worst  prognosis. Epidermal growth factor receptor (EGFR) gene amplification, mutation and re-",https://www.sciencedirect.com/science/article/pii/S0967586809000460,['has']
Newly diagnosed glioblastoma: a review on clinical management,"Glioblastoma is an aggressive primary tumor of the central nervous system. This review will  focus on clinical developments and management of newly diagnosed disease, including a",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278092/,[]
Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment,Glioblastoma multiforme (GBM) is one of the most malignant types of central nervous system  tumors. Despite advances in treatment modalities it remains largely incurable. The objective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563115/,[]
Molecular heterogeneity in glioblastoma: potential clinical implications,"IV astrocytoma, glioblastoma multiforme (GBM glioblastoma most commonly presents de  novo in elderly patients, typically with a short clinical history. In contrast, secondary glioblastoma",https://www.frontiersin.org/articles/10.3389/fonc.2015.00055/full,['presents']
A randomized trial of bevacizumab for newly diagnosed glioblastoma,Background Concurrent treatment with temozolomide and radiotherapy followed by maintenance  temozolomide is the standard of care for patients with newly diagnosed glioblastoma.,https://www.nejm.org/doi/abs/10.1056/NEJMoa1308573,"['diagnosed', 'followed']"
Current promising treatment strategy for glioblastoma multiform: A review,"Glioblastoma multiform (GBM) is a heterogeneous group of primary neoplasm resistant to  conventional therapies. Due to their infiltrative nature it not fully isolated by aggressive surgery,",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661528/,[]
"An integrative model of cellular states, plasticity, and genetics for glioblastoma",and genetic diversity in glioblastoma. We find that malignant cells in glioblastoma exist in  four  The relative frequency of cells in each state varies between glioblastoma samples and is,https://www.cell.com/cell/fulltext/S0092-8674(19)30687-7?dgcid=raven_jbs_etoc_email,"['exist', 'varies', 'find']"
Toward precision medicine in glioblastoma: the promise and the challenges,"of genomic alterations in glioblastoma, targeted agents have  yielded limited clinical efficacy  in glioblastoma, focusing on issues  precision medicine to glioblastoma and the rationale for",https://academic.oup.com/neuro-oncology/article-abstract/17/8/1051/2324956,"['yielded', 'targeted', 'focusing']"
Diagnosis and management of glioblastoma: A comprehensive perspective,"Glioblastoma is the most common malignant brain tumor in  Despite advances in our  understanding of glioblastoma onset, we  For the past few years, the understanding of",https://www.mdpi.com/2075-4426/11/4/258,[]
Corticosteroids compromise survival in glioblastoma,of glioblastoma patient cohorts to determine the prognostic role of steroid administration. A  disease-relevant mouse model of glioblastoma  Cancer Genome Atlas glioblastoma dataset to,https://academic.oup.com/brain/article-abstract/139/5/1458/2468757,"['dataset', 'determine']"
Detection of glioblastoma in biofluids,The detection of glioblastoma (GBM) in biofluids offers potential advantages over existing  paradigms for the diagnosis and therapeutic monitoring of glial tumors. Biofluid-based,https://thejns.org/view/journals/j-neurosurg/129/2/article-p334.xml,"['offers', 'existing']"
Mechanisms of immunotherapy resistance: lessons from glioblastoma,"Glioblastoma (GBM) is the deadliest form of brain cancer, with a median survival of less than  2 years despite surgical resection, radiation, and chemotherapy. GBM’s rapid progression,",https://www.nature.com/articles/s41590-019-0433-y,[]
Advances in radiotherapy for glioblastoma,"External beam radiotherapy (RT) has long played a crucial role in the treatment of  glioblastoma. Over the past several decades, significant advances in RT treatment and image-",https://www.frontiersin.org/articles/10.3389/fneur.2017.00748/full,['played']
Nano-therapies for glioblastoma treatment,"Traditional anti-cancer treatments are inefficient against glioblastoma, which remains one of  the deadliest and most aggressive cancers. Nano-drugs could help to improve this situation",https://www.mdpi.com/2072-6694/12/1/242,['remains']
The role of hypoxia in glioblastoma invasion,"Glioblastoma multiforme (GBM), a grade IV astrocytoma, is the most common and deadly  type of primary malignant brain tumor, with a patient’s median survival rate ranging from 15 to",https://www.mdpi.com/2073-4409/6/4/45,['ranging']
A population-based study of glioblastoma multiforme,"Purpose: To describe (1) the use of surgery and radiotherapy (RT) in the treatment of patients  with glioblastoma (GBM) in Ontario, (2) survival, and (3) proportion of survival time spent in",https://www.sciencedirect.com/science/article/pii/S0360301601015723,"['spent', 'describe']"
Molecular heterogeneity of glioblastoma and its clinical relevance,lead to a new classification of glioblastoma tumors into subtypes with distinct  glioblastoma  molecular subgroups. Intra-tumor heterogeneity of molecular genetic profiles in glioblastoma,https://link.springer.com/article/10.1007/s12253-014-9833-3,['lead']
Mouse models of glioblastoma,"Glioblastoma is one of the most common malignant brain tumors. The prognosis for  deviations  from glioblastoma in situ, glioblastoma cell lines are poor models for glioblastoma (3, 10).",https://europepmc.org/article/nbk/nbk469985,[]
Novel therapies for glioblastoma,"Purpose of Review Glioblastoma (GBM) is the most common malignant primary brain tumor,  and the available treatment options are limited. This article reviews the recent preclinical",https://link.springer.com/article/10.1007/s11910-020-01042-6,[]
